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ABSTRACT
Objective: To evaluate the impact of increased age on
outcome from a strategy of early invasive management
and revascularisation in patients with acute coronary
syndromes (ACS).
Design: Retrospective analysis of a national Acute
Coronary Syndrome registry (ACACIA).
Setting: Multiple Australian (n¼39) centres; 25%
rural, 52% with onsite cardiac surgery.
Patients: Unselected consecutive patients admitted with
conﬁrmed ACS, total n¼2559, median 99 per centre.
Interventions: Management was at the discretion of
the treating physician. Analysis of outcome based on
age >75 years was compared using Cox proportional
hazard with a propensity model to adjust for baseline
covariates.
Main outcome measures: Primary outcome was all-
cause mortality. Secondary outcomes were bleeding
and a composite of any vascular event or unplanned
readmission.
Results: Elderly patients were more likely to present
with high-risk features yet were less likely to receive
evidence-based medical therapies or receive
diagnostic coronary angiography (75% vs 49%,
p<0.0001) and early revascularisation (50% vs 30%,
p<0.0001). Multivariate analysis found early
revascularisation in the elderly cohort to be associated
with lower 12-month mortality hazard (0.4 (0.2e0.7))
and composite outcome (0.6 (0.5e0.8)). Propensity
model suggested a greater absolute beneﬁt in elderly
patients compared to others.
Conclusions: Following presentation with ACS, elderly
patients are less likely to receive evidence-based
medical therapies, to be considered for an early
invasive strategy and be revascularised. Increasing age
is a signiﬁcant barrier to physicians when considering
early revascularisation. An early invasive strategy with
revascularisation when performed was associated with
substantial beneﬁt and the absolute accrued beneﬁt
appears to be higher in elderly patients.
INTRODUCTION
The management of acute coronary
syndromes (ACS) is constantly evolving with
new therapies and interventions tested in
clinical trials. Subjects with ST elevation
myocardial infarction (STEMI) are at very
high early risk, and timely reperfusion
therapy with thrombolysis or primary angio-
plasty substantially reduces mortality.
1 2 In
patients with non-ST elevation syndromes
(NSTEMI), an early invasive strategy with
revascularisation where appropriate is
recommended by international societies and
supported by several prospective trials.
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ARTICLE SUMMARY
Article focus
- To assess the impact of increased age on
invasive management and revascularisation in
patients with acute coronary syndromes.
Key messages
- Age is a barrier to treatment since elderly
patients are less likely to receive evidence-
based medical therapies and invasive
management.
- Invasive management when performed was
associated with substantial beneﬁt; greater
absolute beneﬁt was demonstrated in elderly
patients compared to younger patients.
Strengths and limitations of this study
- The strengths of this study are that the data
are large volume and comprise contemporary
real-world practice.
- The limitations of this study are that the reasons
and decisions for offering or failing to offer
invasive management or evidence-based therapy
are not fully recorded.
- There is no randomisation process within this
registry.
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Open Access ResearchThis strategy is particularly beneﬁcial in patients deemed
to be at high riskdspeciﬁcally those patients with
elevated cardiac biomarkers or dynamic ECG changes.
6
Age in isolation has been considered a risk factor
for patients presenting with ACS yet a paradox exists
that elderly patients >75 years are frequently under-
represented in clinical trials, whereas in clinical practice,
they constitute a signiﬁcant proportion of the patient
population.
78
A poor outcome in the elderly population may be
associated with more complex coronary disease,
increased comorbidity and higher risk of complication
from revascularisation procedures.
9e11 Despite this,
recent studies and large international registries have
shown that the elderly population have substantially
improved outcome with early invasive management, yet
compared to younger patients an interventional strategy
is less likely to be offered.
51 2 e17
The objective of this study was to assess the manage-
ment of ACS in an elderly population using data
taken from a national registry. Speciﬁcally, we planned
to test the hypothesis that age in isolation does not
adversely affect the outcome of patients presenting
with ACS who are managed with an early inter-
ventional strategy and coronary revascularisation. We
also explored the reasons that some elderly patients
are not considered appropriate for an early invasive
strategy.
METHODS
The Acute Coronary Syndrome Prospective Audit
(ACACIA, protocol number PM_L_0051) is a registry of
Australian practice collected between 1 November 2005
and 31 July 2007 involving 39 hospitals across all states
and territories of Australia. These sites were selected to
be representative of rural (25%) and metropolitan
(75%) centres, interventional (83%) and non-interven-
tional (17%) centres and 52% of sites reported onsite
cardiac surgery. Each site sought consecutive enrolment
of between 100 and 150 patients admitted from the
local emergency service for suspected ACS (median, 99).
Patients presenting with ACS thought to be secondary
to major trauma or surgery were excluded. Patients
transferred into study centres were excluded if
more than 12 h had passed since their initial presenta-
tion to enable more accurate assessment of immediate
care.
Ethics approval was obtained from all sites, and written
informed consent was obtained from all conscious
patients. Access to medical records was permitted.
Deﬁnition of ACS and data collection
Patients presenting with suspected STEMI or NSTEMI
were eligible for enrolment. The primary discharge
diagnosis was determined by the investigators at each site
but was conﬁrmed by a central adjudication process.
Stratiﬁcation of data collection diagnoses was also
centrally adjudicated to ensure consistency of enrolment
from each centre. Allocation to non-cardiac chest pain
was made when ACS was excluded or a positive alterna-
tive diagnosis was made, data from these patients were
not included in the principle analyses. Standard clinical
data were recorded including type and results of all
investigations and medications. Early interventional
strategy was deﬁned as angiography at any point during
the index acute admission, including emergency primary
per-cutaneous intervention (PCI) for STEMI but
excluded outpatient angiography. The use, time and
extent of revascularisation by angioplasty (PCI) or
surgery (coronary artery bypass surgery, CABG) was
recorded. All data were collated by trained research
coordinators. All-cause mortality was determined during
the index admission and at 12 months. Any patients lost
to follow-up were referred as a query to the Australian
Institute of Health and Welfare National Death Register
to conﬁrm status and cause of death. Data on non-fatal
vascular events further revascularisation and unplanned
hospital readmissions were recorded from hospital
records and discharge codes.
Statistics
Primary outcome was all-cause mortality at 12 months.
Secondary outcomes were thrombolysis in myocardial
infarction (TIMI) bleeding at 30 days and a composite
of subsequent myocardial infarction, stroke, death and
cardiovascular cause for unplanned hospital read-
mission at 12 months. We deﬁned the elderly popula-
tion as those patients older than 75 years, this value was
selected since patients of this age and above have
frequently been excluded from prospective clinical
trials. Categorical outcomes and parameters were
analysed with c
2 analysis or Fisher’s exact test for 232
comparisons. Multivariate analysis of event-free survival
and overall survival was performed using Cox propor-
tional hazard. Survival curves were plotted to examine
the effect of an early invasive strategy in the aged
cohort. Binary logistic regression was used to evaluate
time-independent outcomes. To evaluate the impact of
an early invasive strategy on 12 month mortality in
patients >75 years and to control for substantial
confounding clinical factors associated with increased
age, a propensity analysis was performed using a non-
parsimonious logistic regression model including age
>75 years, gender, indigenous status, Killip class,
GRACE score, cardiac arrest, normal ECG, ST segment
depression or elevation, shock, pulmonary oedema or
arrhythmia; presence of renal replacement therapy,
dyslipidaemia, hypertension, diabetes, chronic airways
disease, peripheral vascular disease, malignancy or atrial
ﬁbrillation; history of coronary artery disease, myocar-
dial infarction, PCI, CABG or stroke (c-index: 0.89). A
logistic regression model for survival until 12 months
including age, propensity score and early invasive
management was then undertaken. This model was used
to predict the expected mortality in ascending strata of
age groups. These data are presented across the age
groups further stratiﬁed by use of early invasive
management. All data were analysed using commercially
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ACACIA elderly analysisavailable software STATA V.13. Signiﬁcance was sought
at the 5% level.
RESULTS
Baseline characteristics
A total of 3402 patients were enrolled, and vital status
was available for 3393 at 1 year. Discharge diagnosis of
STEMI was recorded in 717 patients, NSTEMI in 1027
and unstable angina in 815 giving a study population of
2559. Patients excluded from analyses (843) were
assigned to a variety of non-ACS diagnoses (including
but not exclusive to: musculoskeletal chest pain, peri-
carditis, respiratory infection and pulmonary embolism).
Elderly patients, >75 years comprised 27% (n¼683) of
the study population, baseline variables are shown in
table 1. The younger group were more likely to be active
smokers and to present with cardiac arrest. The elderly
group presented more frequently in association with
haemodynamic disturbance and other comorbidity.
In hospital management
During in hospital care, the elderly group were less likely
to be treated with evidence-based medical therapies and
were less frequently referred for angiography (79% vs
49%, p¼0.0001) (table 2). Revascularisation as a whole
was therefore less frequently performed in the elderly
cohort. The disparity in revascularisation was driven
primarily by less frequent referral for diagnostic angio-
gram. If angiography was performed, then the rates of
revascularisation were more comparable (61% vs 66%,
p¼0.04). Logistic regression of the whole cohort iden-
tiﬁed 13 variables that independently contributed to
mortality at 12 months (ﬁgure 1). Among these vari-
ables, an age >75 years increased mortality risk (OR 1.7
(95% CI 1.2e2.6)) and early revascularisation reduced
risk (OR 0.4 (95% CI 0.2e0.7)). Division of the data into
subjects older than 75 years found early revascularisation
to remain highly protective in terms of risk of all-cause
mortality (OR 0.4 (95% CI 0.2e0.7)) and composite
outcome (OR 0.6 (95% CI 0.5e0.8)) (ﬁgures 2 and 3).
Predicted mortality based on the propensity model
suggested further beneﬁt associated with early revascu-
larisation and incrementally greater beneﬁt was
projected in the higher age brackets (ﬁgure 4). We
explored the factors associated with for non-referral for
angiogram and for not performing revascularisation.
Independent variables that appeared to contribute to
non-referral for angiogram included age over 75 years,
female gender, presence of diabetes and history of
myocardial infarction (ﬁgure 5). Once an angiogram
had been performed, fewer variables inﬂuenced the
decision to perform revascularisation and neither
gender nor age >75 years was contributory.
TIMI bleeding
There were 123 episodes of TIMI bleeding in the study
cohort within 30 days of index presentation. Overall, age
>75 years was not a risk factor for bleeding (HR 1.3
(0.86e1.9)) nor was there excess bleeding in the old
versus younger cohorts (5% vs 4%, p¼0.6). Early
Table 1 Baseline characteristics
Variable <75 years (N[1876) % >75 years (N[683) % c
2 (Fisher’s)
Male 1380 74 372 55 0.001
Dyslipidaemia 1134 60 418 61 0.7
Current smoker 570 30 34 5 0.001
Known coronary disease 851 45 438 64 0.001
Previous MI 479 26 251 37 0.001
Chronic heart failure 93 5 121 18 0.001
Previous PCI 356 19 123 18 0.3
Previous CABG 234 12 150 22 0.001
Diabetes 512 27 171 25 0.25
Hypertension 1125 60 510 75 0.001
Atrial ﬁbrillation 137 7 139 20 0.001
Peripheral vascular disease 82 4 80 12 0.001
Malignancy 96 5 84 12 0.001
Elevated cardiac biomarkers 1384 74 485 71 0.163
Normal ECG 506 27 155 23 0.03
ST segment deviation
(including BBB)
894 48 338 50 0.4
ST elevation 577 31 138 20 0.001
ST depression 224 12 123 18 0.001
Left bundle branch block 73 4 72 11 0.001
Killip 1 1589 85 448 66 0.001
Pulmonary oedema 72 4 60 9 0.001
Cardiac arrest 68 3.6 11 1.6 0.009
Arrhythmia on presentation 115 6 40 6 0.8
BBB, bundle branch block; CABG, coronary artery bypass surgery; MI, myocardial infarction; PCI, per-cutaneous intervention.
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ACACIA elderly analysisrevascularisation was associated with a substantially
higher risk of bleeding in both the young (10.5
(5.1e21)) and aged (14.9 (5.6e40)) cohort, and this
relationship was independent of the use of aspirin,
clopidogrel and anticoagulation at the time of presen-
tation. Comparison limited to the patients who received
early revascularisation (n¼1134) did reveal excess
bleeding in the aged cohort compared to the younger
group (13.2% vs 7.6%, p¼0.01).
DISCUSSION
The ACACIA data set provides an outstanding insight
into the management of ACS sourcing data from
different types of hospital. These data in concordance
with other studies show that elderly patients are more
often managed conservatively, a particular barrier
appears to be at the level of referral for diagnostic
angiogram with less than half of the patients >75 years
receiving this investigation. This observation is not a new
ﬁnding
12 18 and provides some evidence of referral bias;
most young patients are offered an angiogram, whereas
most elderly patients are not. Unfortunately, our data do
not record the reason for this disparity since we do not
Table 2 In hospital management
Variable
<75 years
(N[1876) %
>75 years
(N[683) % p Value
Aspirin 1672 89 528 77 0.001
Clopidogrel 1234 66 357 52 0.001
2b3a Agent 163 8.7 36 5 0.004
Low-molecular-weight heparin 1410 75 520 76.1 0.6
Angiotensin-converting enzyme inhibitor 1110 59 370 54 0.02
Angiotensin receptor antagonist 243 13 116 17 0.009
HMG-CoA enzyme inhibitor 1635 87 537 79 0.001
B-blocker 1346 72 446 65 0.002
Functional test for ischaemia 188 10 43 6.3 0.004
Diagnostic angiography 1401 75 335 49 0.001
Echocardiogram 758 40 293 42 0.26
Angioplasty 808 43 169 25 0.001
Coronary surgery 154 8.2 46 6.7 0.2
Revascularisation if angiogram 931 from 1401 66 203 from 335 61 0.04
Reperfusion if (STEMI) 420 72 80 60 0.008
Primary PCI 256 44 50 38 0.2
Rescue PCI 33 6 2 1.5 0.05
TIMI bleed 83 4 34 5 0.5
Time to diagnostic angiogram (days)
excluding primary PCI
1.0264.5 2.664.0 0.5*
Time to primary PCI (minutes) 180.7642.1 123661.4 0.3*
c
2 Statistic unless stated.
*Unpaired t test.
PCI, per-cutaneous intervention; STEMI, ST elevation myocardial infarction; TIMI, thrombolysis in myocardial infarction.
Figure 1 Box plot indicating HR contributing to all-cause
mortality at 1 year in acute coronary syndromes cohort in
multivariate analysis. ACE, angiotensin converting enzyme
inhibitor; ARA, angiotensin receptor antagonist; CHF, chronic
heart failure; eREVASC, early revascularisation within the
index admission; PCI, per-cutaneous intervention.
Figure 2 Survival curve of elderly acute coronary syndromes
cohort with respect to early revascularisation.
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ACACIA elderly analysishave data on generalised extreme frailty, patient choice
or a positive decision to palliate patients based on
extensive comorbidity. There is no doubt that frailty may
inﬂuence decision to treat individual patients conserva-
tively,
19 but it is extremely unlikely that these factors
alone account for the fewer number or elderly patients
offered an early invasive strategy. The reason for the
apparent reluctance of clinicians to offer invasive
management to some of their elderly patients is not
clear. An obvious observation is that increased age is
associated with mortality, yet the effect of age >75 years
was less inﬂuential on mortality risk than presence of
diabetes, heart failure and haemodynamic disturbance
on presentation. Another possibility is the perceived risk
of bleeding, we did observe a higher rate of TIMI
bleeding at 30 days in the elderly cohort, although this
effect did not translate to a change of mortality or
composite outcome at 12 months. Furthermore, in our
adjusted analysis, the absolute beneﬁt of early revascu-
larisation was positively associated with increased strati-
ﬁcations of age. This analysis is unsurprising since those
patients at highest risk (such as the elderly) stand to gain
most from an early invasive strategy, and this fact is
consistent with the substantial impact of age on risk in
scores, such as the GRACE score.
20 The phenomenon of
elderly patients deriving a greater absolute beneﬁt than
younger patients has previously been reported in
subgroup analyses of the TACTICS TIMI 18 trial
16 and
from the crusade registry.
17 The data from the ACACIA
registry reinforce the message of these trials and other
data demonstrating that age is not a bar to the beneﬁts
associated with invasive management and increased age
should not be the dominant factor when contemplating
management following hospitalisation with ACS. In the
real world, some patients elect not to pursue an early
invasive strategy, and this choice may be made more
frequently by elderly patients, who may have concerns
about their own frailty and long-term morbidity. Physi-
cians may also judge that a patient has such substantial
comorbidity that a palliative or limited approach should
be undertaken.
21 Despite these case-speciﬁc manage-
ment decisions, it is clear from our data, however, that
the elderly ACS population are underinvestigated and
undertreated, and this may deny these patients the
substantial beneﬁt that is seen within 12 months. We
encourage all physicians who manage patients with ACS
to avoid using advanced age as reason to manage some
patients conservatively.
CONCLUSIONS
Elderly patients comprise a large group of the ACS
population. Despite having higher baseline risk, they are
less likely to be offered evidence-based medical therapies
and substantially less likely to be investigated invasively
Figure 3 Freedom from composite outcome in elderly acute
coronary syndromes cohort with respect to early
revascularisation. CVA, cerebrovascular accident (stroke); MI,
myocardial infarction.
Figure 4 Predicted absolute mortality (error bars are SD) at
1 year calculated from propensity model.
Figure 5 Box plot indicating HR contributing to likelihood of
referral for diagnostic coronary angiography in the acute
coronary syndromes cohort. AF, atrial ﬁbrillation; CHF, chronic
heart failure; COPD, chronic obstructive pulmonary disease;
MI, myocardial infarction; PCI, per-cutaneous intervention;
STEMI, ST elevation myocardial infarction.
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ACACIA elderly analysiswith a view to early revascularisation. The effect of an
early invasive strategy with revascularisation was associ-
ated with improvements in survival and in the composite
outcome of myocardial infarction, stroke, death and
cardiovascular cause for readmission, at the expense of
a higher incidence of TIMI bleeding. Adjustment for
baseline covariates using a propensity model suggested
greater absolute beneﬁt in patients at advanced age.
Limitations
The ACACIA data represent a real-world registry; indi-
vidual decisions on patient management such as reasons
for not offering an early invasive strategy were not
recorded. Hence, the issue of residual selection bias
leading to confounding cannot be fully accounted for.
While other techniques such as ‘instrument variable
analysis’ offer alternative approaches to this problem,
determining a viable instrument remains challenging.
Nevertheless, these data are consistent with other
reported literature. Since there was no randomisation
process in this registry data, all statistical relationships are
reported as associations rather than implied causation.
The geographical challenges of healthcare in Australia
are reﬂected in some of the data such as persisting use of
thrombolysis and rescue or convalescent angioplasty.
Our data include all patients diagnosed ACS including
those with STelevation myocardial infarction; we did not
exclude these patients from analyses since the main
interest of the paper was on the impact on age overall,
rather than an analysis of a select population of ACS.
Our data, therefore, differ from the other major studies
of age on outcome that were limited to non-STelevation
myocardial infarctions.
5 17 18
Transfer from a non-interventional centre to an
interventional centre was positively associated with an
early invasive strategy. It is possible that further referral
bias occurs at this level since cardiologists may preselect
those patients in whom they expect the best outcomes,
especially if transfer involves air travel. However, our data
were carefully selected to be representative of real-world
cardiology practice including both metropolitan surgical
centres and rural district hospitals and evidence of
bias in referral based on age or transfer is worthy of
discussion.
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